Renzo Canetta, M.D.

CAREER: During his early years at the Istituto Nazionale Tumori in Milan, Italy (1974-1980) Dr.Canetta focus was on clinical trials in lymphomas and gastrointestinal tumors, among others. Since joining Bristol_Myers Squibb (BMS) in 1980, he held numerous roles of increasing responsibility and leadership, including head of clinical cancer research; head of development, life cycle management; vice-president oncology global clinical research and finally, vice-president of global R&D oncology policy. His experience can be summarized with the introduction of 18 new BMS drugs (two of them outside oncology) and the approval of more than 50 regulatory dossiers for additional indications/formulations. including some outside of oncology.

Dr.Canetta retired from BMS on August 14, 2015 and currently consults/cooperates with non-for-profit organizations,government agencies and professional societies. EDUCATION: Universita’ degli Studi, Milan,Italy : Graduate, Medicine and Surgery (m.D.),1976; Istituto Nazionale Tumori, Milan, Italy : State Certification, Clinical Oncology,1977; Universita’ degli Studi, Milan, Italy : Board Certification, Clinical and Laboratory Hematology, 1979.